Simultaneous treatment of moderate-to-severe horizontal frontalis lines, glabellar lines, and lateral canthal lines with onabotulinumtoxinA, from the subject’s perspective: Patient-reported satisfaction and impact outcomes from a phase 3 double-blind study

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Dermatology Vol. 79; no. 3; p. AB262
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2018
Online AccessGet full text

Cover

Loading…
More Information
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2018.05.1037